Label: HEMORRHOIDALOINTMENT- mineral oil, petrolatum, phenylephrine hci ointment

  • NDC Code(s): 69396-133-20
  • Packager: Trifecta Pharmaceuticals USA LLC
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: OTC monograph final

DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Drug Label Information

Updated June 14, 2023

If you are a consumer or patient please visit this version.

  • Drug Facts

  • Active Ingredient

    Phenylephrine HCI 0.25%

  • Purpose

    Vasoconstrictor

  • Active Ingredient

    Mineral Oil 14%

  • Purpose

    Protectant

  • Active Ingredient

    Petrolatum 74.9%

  • Purpose

    Protectant

  • Uses

    • Helps relieve the local itching and discomfort associated with hemorrhoids
    • Temporarily shrinks hemorrhoidal tissue and relieves burning
    • Temporarily provides a coating for relief of anorectal discomforts
    • Temporarily profects the inflamed, irritated anorectal surface to help make bowel movements less painful
    • Introduction of applicator into the rectum causes additional pain
  • Warnings

    For external and/or anorectal use only

    Ask doctor before use if you have

    • heart disease
    • high blood pressure
    • thyroid disease
    • diabetes
    • trouble urinating due to an enlarged prostate gland

    Ask doctor before use if you are presently taking a prescription drug for high blood pressure or depression

  • Stop Use and Ask Doctor if

    • Bleeding occurs
    • Condition worsens or does not improve within 7 days
  • If Pregnant or Breast-Feeding

    Ask a doctor before use

  • Keep out of reach of children

    If swallowed get medical help or contact a Poison Control Center right away

  • When using this product

    When using this product do not exceed the recommended dosage unless directed by a doctor

  • Directions

    Children under 12 years of age: ask a doctor before use.

    Adults: when practical, clean the affected area by patting or blotting with an appropriate cleansing wipe

    • Gently dry by patting or blotting with a tissue or soft cloth before applying
    • When first opening tube, remove foil seal
    • For intrarectal use: remove protective cover from applicator and attach to tube
    • Lubricate applicator well, then gently insert applicator into rectum
    • Thoroughly clean applicator and replace protective cover after each use
    • Clean the affected area and pat or dab dry before applying ointment
    • Apply externally to the affected area up to 4 times daily, especially at night, in the morning or after each bowel movement
    • also apply ointment to external area.
  • Other Information

    • Store at room temperature 20°-25°C (68°-77°F)
  • Inactive Ingredients

    Beeswax, Benzoic Acid, Cetyl alcohol, Glycerol Methylparaben, Polyoxyethylene lauryl ether, Propylparaben, Stearyl alcohol

  • Questions

    Call 1-800-883-0085

  • Distributed By

    Proudly Distributed by

    Assocated wholesale grocers inc

    kansas city Kansas 66106

    Call 1 844 2921112 for product information

    www.bestchoicebrand.com

    Preparation H is a registered trademark of Glaxosmithkline consumer healthcare holdings US

  • PRINCIPAL DISPLAY PANEL

    Best Choice Hemorrhoidal Ointment 2oz 050923 CDER

  • INGREDIENTS AND APPEARANCE
    HEMORRHOIDALOINTMENT 
    mineral oil, petrolatum, phenylephrine hci ointment
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:69396-133
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    MINERAL OIL (UNII: T5L8T28FGP) (MINERAL OIL - UNII:T5L8T28FGP) MINERAL OIL14 g  in 100 g
    PETROLATUM (UNII: 4T6H12BN9U) (PETROLATUM - UNII:4T6H12BN9U) PETROLATUM74.9 g  in 100 g
    PHENYLEPHRINE HYDROCHLORIDE (UNII: 04JA59TNSJ) (PHENYLEPHRINE - UNII:1WS297W6MV) PHENYLEPHRINE HYDROCHLORIDE0.25 g  in 100 g
    Inactive Ingredients
    Ingredient NameStrength
    BENZOIC ACID (UNII: 8SKN0B0MIM)  
    PROPYLPARABEN (UNII: Z8IX2SC1OH)  
    METHYLPARABEN (UNII: A2I8C7HI9T)  
    YELLOW WAX (UNII: 2ZA36H0S2V)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    STEARYL ALCOHOL (UNII: 2KR89I4H1Y)  
    CETYL ALCOHOL (UNII: 936JST6JCN)  
    LAURETH-15 (UNII: 002FR4N8OV)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:69396-133-201 in 1 BOX06/01/2023
    156.8 g in 1 TUBE; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC monograph finalpart34606/01/2023
    Labeler - Trifecta Pharmaceuticals USA LLC (079424163)